The Beauty Health Company (SKIN)
- Previous Close
3.4300 - Open
3.4500 - Bid 3.5300 x 1200
- Ask 3.5800 x 500
- Day's Range
3.3900 - 3.5750 - 52 Week Range
1.3500 - 10.9800 - Volume
1,388,315 - Avg. Volume
2,445,108 - Market Cap (intraday)
438.279M - Beta (5Y Monthly) 1.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7600 - Earnings Date May 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.56
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
www.beautyhealth.com881
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SKIN
Performance Overview: SKIN
Trailing total returns as of 5/9/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SKIN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SKIN
Valuation Measures
Market Cap
423.47M
Enterprise Value
652.73M
Trailing P/E
--
Forward P/E
28.57
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.13
Price/Book (mrq)
7.13
Enterprise Value/Revenue
1.64
Enterprise Value/EBITDA
-11.66
Financial Highlights
Profitability and Income Statement
Profit Margin
-25.16%
Return on Assets (ttm)
-8.47%
Return on Equity (ttm)
-88.43%
Revenue (ttm)
397.99M
Net Income Avi to Common (ttm)
-100.12M
Diluted EPS (ttm)
-0.7600
Balance Sheet and Cash Flow
Total Cash (mrq)
523.02M
Total Debt/Equity (mrq)
1,266.69%
Levered Free Cash Flow (ttm)
24.91M
Research Analysis: SKIN
Company Insights: SKIN
SKIN does not have Company Insights